Development of CTCL-Seq, a Rapid, High Throughput Method to Simultaneously Assay All Known Oncogenes and Tumor Suppressors in Cutaneous T Cell Lymphoma

Project: Research project

Project Details


We are developing a rapid, high throughput genetic test to simultaneously assess all known oncogenes and tumor suppressors in Cutaneous T Cell Lymphoma. This test will be useful for diagnosis and staging of patients and should pave the way for tailoring therapeutic strategies for each patient based on molecular data.
Effective start/end date3/1/166/28/17


  • Skin Cancer Foundation (Agreement 1/5/16)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.